Epidemiology and prevention of group A streptococcal infections: Acute respiratory tract infections, skin infections, and their sequelae at the close of the Twentieth Century

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 205-210

  Carapetis, Jonathan R ^a,b,c   Currie, Bart J ^a,b   Kaplan, Edward L ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

CONFERENCE PAPER; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE TRANSMISSION; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MALE; PHARYNGITIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PYODERMA; RESPIRATORY TRACT INFECTION; RISK FACTOR; SKIN INFECTION; STREPTOCOCCUS INFECTION;

EID: 0033010685     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515114     Document Type: Conference Paper

References (67)

1. 1. Quinn RW. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis 1989;11:928-53.
2. 2. Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century: influences and dynamics of populations and pathogens - a failure to realise prevention? Circulation 1993;88:1964-72.
3. 3. World Health Organization. Strategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting. Bull World Health Organ 1995;73: 583-7.
4. 4. World Health Organization. Rheumatic fever and rheumatic heart disease - report of a WHO study group. World Health Organ Tech Rep Ser 1988;764:1-58.
5. 5. Dingle JH, Badger GF, Jordan WS Jr. Streptococcal infections. In: Illness in the home; a study of 25,000 illnesses in a group of Cleveland families. Cleveland: Press of Western Reserve University, 1964:97-117.
6. 6. Anthony BF, Kaplan EL, Wannamaker LW, Chapman SS. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Am J Epidemiol 1976;104:652-66.
7. 7. Kaplan EL. Public health implications of group A streptococcal infections in the 1990s. Pediatr Infect Dis J 1994;13:580-3.
8. 8. Wannamaker LW. The epidemiology of streptococcal infections. In: McCarty M, ed. Streptococcal infections. New York: Columbia University Press, 1954:157-75.
9. 9. Hall CB. Cited in: Gray BM. Streptococcal infections. In: Evans AS, Brachman PS, eds. Bacterial infections of humans: epidemiology and control. New York: Plenum Medical Book Company, 1991:652.
10. 10. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994;124:9-16.
11. 11. Kaplan EL, Johnson DR, Cleary PP. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-80s. J Infect Dis 1989;159:101-3.
12. 12. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992;166: 374-82.
13. 13. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr 1980;97:337-45.
14. 14. Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971;123:490-501.
15. 15. Ogunbi O, Fadahunsi HO, Ahmed I, et al. An epidemiological study of rheumatic fever and rheumatic heart disease in Lagos. J Epidemiol Community Health 1978;32:68-71.
16. 16. Gupta R, Prakash K, Kapoor AK. Subclinical group A streptococcal throat infection in school children. Indian Paediatric Journal 1992;29: 1491-4.
17. 17. Parker MT, Bassett DCJ, Maxted WR, Arneaud JD. Acute glomerulonephritis in Trinidad: serological typing of group A streptococci. J Hyg Camb 1968;66:657-75.
18. 18. Kaplan EL. Recent evaluation of antimicrobial resistance in beta-hemolytic streptococci. Clin Infect Dis 1997;24(suppl 1):S89-92.
19. 19. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995;21:1378-85.
20. 20. Rammelkamp CH, Denny FW, Wannamaker LW. Studies on the epidemiology of rheumatic fever in the armed services. In: Thomas L, ed. Rheumatic fever - a symposium. Minneapolis: University of Minnesota Press, 1952:72-89.
21. 21. Coburn AF, Young DC. The epidemiology of hemolytic streptococcus during World War II in the United States Navy. Baltimore: Williams & Wilkins, 1949.
22. 22. Cornfeld D, Hubbard JP. A four-year study of the occurrence of beta-hemolytic streptococci in 64 school children. N Engl J Med 1961;264: 211-5.
23. 23. Rantz LA, Maroney M, DiCaprio JM. Infection and reinfection by hemolytic streptococci in early childhood. In: Thomas L, ed. Rheumatic fever - a symposium. Minneapolis: University of Minnesota Press, 1952:90-103.
24. 24. Sharrett AR, Finklea JF, Potter EV, Poon-King T, Earle DP. The control of streptococcal skin infections in South Trinidad. Am J Epidemiol 1974;99:408-13.
25. 25. Carapetis J, Currie B. Clinical epidemiology of rheumatic fever and rheumatic heart disease in tropical Australia. Adv Exp Med Biol 1997;418: 233-6.
26. 26. Carapetis J, Connors C, Yarmirr D, Krause V, Currie B. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 1997;16:494-9.
27. 27. Carapetis J, Gardiner D, Currie B, Mathews JD. Multiple strains of Streptococcus pyogenes in skin sores of aboriginal Australians. J Clin Microbiol 1995;33:1471-2.
28. 28. Gardiner DL, Sriprakash KS. Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia. J Clin Microbiol 1996;34:1448-52.
29. 29. Wannamaker LW. Differences between streptococcal infections of the throat and of the skin. (Second of two parts.) N Engl J Med 1970;282: 78-85.
30. 30. Bessen DE, Hollingshead SK. Allelic polymorphism of emm loci provides evidence for horizontal gene spread in group A streptococci. Proc Natl Acad Sci USA 1994;91:3280-4.
31. 31. Bisno AL, Pearce IA, Stollerman GH. Streptococcal infections that fail to cause recurrences of rheumatic fever. J Infect Dis 1977;136:278-85.
32. 32. Lennon D, Martin D, Wong E, Taylor LR. Longitudinal study of poststreptococcal disease in Auckland; rheumatic fever, glomerulonephritis, epidemiology and M-typing 1981-6. N Z Med J 1988;101:396-8.
33. 33. Martin DR, Voss LM, Walker SJ, Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994;13:264-9.
34. 34. Kechrid A, Kharrat H, Bousnina S, Kriz P, Kaplan EL. Acute rheumatic fever in Tunisia: serotypes of group A streptococci associated with rheumatic fever. Adv Exp Med Biol 1997;418:121-3.
35. 35. Poon-King T, Mayon-White RT, Harnaryan C, et al. Rheumatic fever and glomerulonephritis. In: Parker MT, ed. Pathogenic streptococci: proceedings of the 7th International Symposium on Streptococci and Streptococcal Diseases held in September 1978. Surrey: Reedbooks, 1979:124-5.
36. 36. Tewodros W, Muhe L, Daniel E, Schalen C, Kronvall G. A one-year study of streptococcal infections and their complications among Ethiopian children. Epidemiol Infect 1992;109:211-25.
37. 37. Popat KD, Riding WD. Acute rheumatic fever following streptococcal wound infection. Postgrad Med J 1976;52:165-70.
38. 38. Dillon HC Jr. Post-streptococcal glomerulonephritis following pyoderma. Rev Infect Dis 1979;1:935-45.
39. 39. Markowitz M. Streptococcal disease in developing countries. Pediatr Infect Dis J 1991;10(suppl):S11-4.
40. 40. el-Kholy A, Sorour AH, Houser HB, et al. A three-year prospective study of streptococcal infections in a population of rural Egyptian school children. J Med Microbiol 1973;6:101-10.
41. 41. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics 1996;97:949-54.
42. 42. Barnham M, Thornton TJ, Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet 1983;1:945-8.
43. 43. Bisno AL, Collins CM, Turner JC. M proteins of group C streptococci isolated from patients with acute pharyngitis. J Clin Microbiol 1996;34:2511-5.
44. 44. Collins CM, Kimura A, Bisno AL. Group G streptococcal M protein exhibits structural features analogous to those of class 1 M protein of group A streptococci. Infect Immun 1992;60:3689-96.
45. 45. Sriprakash KS, Hartas J. Lateral genetic transfers between group A and G streptococci for M-like genes are ongoing. Microb Pathog 1996;20: 275-85.
46. 46. Simpson WJ, Musser JM, Cleary PP. Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci. Infect Immun 1992;60: 1890-3.
47. 47. Kumar R. Controlling rheumatic heart disease in developing countries. World Health Forum 1995;16:47-51.
48. 48. WHO Cardiovascular Diseases Unit and principal investigators. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from phase I (1986-90). Bull World Health Organ 1992;70:213-8.
49. 49. McCormick JB, Fraser DW. Disease control programs in the United States: control of streptococcal and poststreptococcal disease. JAMA 1978;239:2359-61.
50. 50. Brundage JF, Gunzenhauser JD, Longfield JN, et al. Epidemiology and control of acute respiratory diseases with emphasis on group A beta-hemolytic streptococcus: a decade of U.S. Army experience. Pediatrics 1996;97:964-70.
51. 51. Phibbs B, Becker D, Lowe C, et al. The Casper Project - an enforced mass-culture streptococcic control program. JAMA 1958;166:1113-9.
52. 52. Zimmerman RA, Biggs BA, Bolin RA, et al. An effective program for reducing group A streptococcal prevalence. Pediatrics 1971;48: 566-72.
53. 53. Johnson S, Streamer C, Williams P. An evaluation of a streptococcal control program. Am J Public Health 1964;54:487-500.
54. 54. Coulehan JL, Baacke G, Welty TK, Goldtooth NL. Cost-benefit of a streptococcal surveillance program among Navajo Indians. Public Health Rep 1982;97:73-7.
55. 55. Atha M, Enos E, Frank C, et al. How an American Indian tribe controlled the streptococcus. World Health Forum 1982;3:423-8.
56. 56. Neilson G, Streatfield RW, West M, Johnson S, Glavin W, Baird S. Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Establishment of a prophylactic program. Med J Aust 1993;158:316-8.
57. 57. Hanna J, O'Rourke S. Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Med J Aust 1993;158:793.
58. 58. Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr 1992;121:569-72.
59. 59. Gordis L. Effectiveness of comprehensive care programs in preventing rheumatic fever. N Engl J Med 1973;289:331-5.
60. 60. Bach JF, Chalons S, Forier E, et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 1996;347: 644-8.
61. 61. Kaplan EL, Johnson DR, Nanthapisud P, Sirilertpanrana S, Chumdermpadetsuk S. A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications. Bull World Health Organ 1992;70:433-7.
62. 62. Relf WA, Martin DR, Sriprakash KS. Identification of sequence types among the M-nontypeable group A streptococci. J Clin Microbiol 1992;30:3190-4.
63. 63. Gardiner D, Hartas J, Currie B, Mathews JD, Kemp DJ, Sriprakash KS. Vir typing: a long-PCR typing method for group A streptococci. PCR Methods Appl 1995;4:288-93.
64. 64. Norton RE, Heuzenroeder M, Manning PA. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for the serodiagnosis of rheumatic fever. FEMS Immunol Med Microbiol 1996;16:267-71.
65. 65. Steinhoff MC, Abd el Khalek MK, Khallaf N, et al. Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children. Lancet 1997;350:918-21.
66. 66. Kaplan EL. Clinical guidelines for group A streptococcal throat infections [commentary]. Lancet 1997;350:899-900.
67. 67. Taplin D, Porcelain SL, Meinking TL, et al. Community control of scabies: a model based on use of permethrin cream. Lancet 1991;337:1016-8.